Chief Executive of the TSB bank, Paul Pester, poses outside the bank's Baker Street branch in London September 9, 2013. Britain's 200-year-old TSB bank returned to the high street on Monday after an 18-year absence, the result of action by regulators and the government to introduce greater competition for the country's banks following several consumer scandals.

Good morning! Here’s what you need to know.

1. Customers of Britain’s TSB complained they were locked out of their online banking again on Tuesday only two months after a botched IT upgrade plunged the bank into chaos. The bank said that the issue had been resolved but a number of customers took to Twitter to flag that they were still unable to access their accounts. Some said computers were also down in their local branches.

2. American Airlines said it plans to no longer offer plastic straws and stir sticks in its lounges and onboard its flights. Starting this month, American said drinks in its airport lounges will instead feature biodegradable straws and wooden stir sticks.

3. A former Apple employee was charged with theft of trade secrets. The complaint said that the former employee, Xiaolang Zhang, disclosed intentions to work for a Chinese self-driving car startup and booked a last-minute flight to China after downloading the plan for a circuit board for the self-driving car.

4. Airbus scored a key victory, with U.S. airline JetBlue announcing it would buy 60 of its A220-300 narrowbody jets. It’s the first major order for the planemaker’s newly rebranded program as its battle with rival Boeing intensifies.

5. Saudi Arabia has arrested a defense ministry official on charges of receiving a 1 million riyal ($267,000) bribe and abusing his position. “The official sought to facilitate irregular procedures for the disbursement of financial dues to a company, taking advantage of his professional influence,” a statement said.

6. Two former employees of rival biopharmaceutical companies were convicted for using their access to confidential information about drug studies to profit in the stock market through insider trading. A federal jury in Boston found Schultz Chan, a former Akebia Therapeutics Inc employee, and …read more

Source:: Business Insider


(Visited 3 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *